Understanding Insurance Coverage & Cost-Share Assistance with Marissa Shackleton

April 29, 2020

What Infusion Operators Should Know about Medically Integrated Dispensing

November 17, 2026

Operations

By Bridget Chavez-Kinder and Mark Walsh, Coral Connect

With margins shrinking and payors steering specialty drugs away from buy-and-bill, more infusion operators are asking about medically integrated dispensing (MID).

MID started in oncology, where practices began dispensing oral cancer therapies on-site instead of sending patients to outside mail-order pharmacies. The goal was to reduce access delays and fragmented care, and to better monitor adherence. In the MID model, the prescriber and care team track patient dosing, tolerance, adherence, and disease progression between visits.

If you already infuse your patients in-house, MID can seem like a natural next step. You’d have the same patients, the same clinical decision-making, one patient record to monitor, and no additional middleman between you and your patients. But payors don’t see it that way. They treat administration and dispensing as two separate benefits. Understanding that distinction is the first step in deciding whether MID is right for your business.

Medical Benefit vs. Pharmacy Benefit

When you administer a drug, you are a medical provider billing the patient’s medical benefit. When you dispense the drug, you bill the pharmacy benefit as a dispensing practitioner under the physician’s own NPI, DEA registration, and state license (where state law permits), rather than as a licensed pharmacy. The move from infusion (medical benefit) to MID (pharmacy benefit) changes the payor, the claim type, the reimbursement method, and the patient’s out-of-pocket cost.

 Medical BenefitPharmacy Benefit
You bill asMedical providerDispensing practitioner (where state law permits)
Claim codeHCPCS J-codeNDC, adjudicated in real time
Typical paymentPercentage of ASPBenchmark such as AWP plus a dispensing fee (minus PBM fees)
NetworkYour existing medical contractsPBM network, with many specialty drugs limited to PBM-designated specialty pharmacies

Your existing medical contracts don’t automatically cover dispensing, which is a common assumption worth testing early when you consider MID. The pharmacy benefit is typically administered by a PBM, so you’ll need to understand your network access for the drugs you plan to dispense, along with the credentialing requirements that come with it. Model your pharmacy-side margin before making any reimbursement assumptions.

MID vs. Opening a Pharmacy

Once you understand the benefit question, the next decision is structural. Will you dispense as a medically integrated practice, or open a pharmacy? From the outside, the two can look nearly identical. Both need inventory, dispensing software, appropriate licensure, and staff who understand pharmacy claims. The difference is who the operation serves, and that difference shapes how state regulators, manufacturers, and distributors will view you. It also shapes how much work it takes to get started. An MID runs on the physician’s own NPI, DEA, and Health Industry Number (HIN). Many PBMs enroll the practice as a dispensing practitioner rather than a pharmacy. In our experience, where state law allows physician dispensing, an MID can be set up in four to five months, compared to nine to twelve months for a new pharmacy.

Start with Your State

Each state’s board of pharmacy and medical board determine whether a physician may dispense under their own license, whether a practice must hold a pharmacy permit, and who may own one. Some states allow physician dispensing with little more than a registration, while others restrict it heavily. Where physician dispensing is limited to narrow exceptions, a practice running an MID typically must license it as a pharmacy and meet the same standards as any retail pharmacy.

State law is only part of the picture. Physician-owned dispensing can also raise federal considerations, including the physician self-referral law (Stark Law) and the Anti-Kickback Statute, particularly when you dispense to Medicare or Medicaid patients. How these apply depends on how your practice and dispensing operation are structured, so involve healthcare counsel early.

Class of Trade

What separates an MID from a pharmacy is the business model, and this is where class of trade comes in. Every location that buys drugs is identified by a HIN, issued by the Health Industry Business Communications Council (HIBCC). That record carries a class of trade such as physician office, clinic, retail pharmacy, or specialty pharmacy. Manufacturers and wholesalers rely on that designation when deciding which contracts, pricing, and limited-distribution products a customer can access.

A traditional pharmacy fills prescriptions from any prescriber for any member of the public and is classified accordingly. An MID dispenses only to the practice’s own patients, on prescriptions from the practice’s own providers, as an extension of care already delivered in the clinic. For that reason, an MID may qualify for a physician or clinic class of trade even where state law requires it to be licensed as a pharmacy. Confirm with your wholesaler before you decide anything.

Your HIN and the Declaration Form

For most infusion practices, the HIN is already in place. Once the location holds a HIN with the appropriate class of trade, the declaration form is how you support it with each manufacturer or distributor. These forms can ask you to attest to how product will be used, including who will receive it, who will prescribe it, whether it will be resold or transferred, and whether you will fill prescriptions from outside providers.

To support a physician or clinic class of trade, your answers may need to reflect an “own-use” model, in which product is purchased for and dispensed only to patients of the provider or physician group. A traditional pharmacy generally can’t make that attestation, because serving outside prescribers is its purpose. Even with the HIN and declaration form in hand, the outcome isn’t automatic, because each manufacturer makes its own determination.

Why the Attestation Matters

The attestation isn’t a formality. What you sign becomes the standard manufacturers measure your operations against, and they may review your purchasing and dispensing data to check. Filling outside prescriptions, sharing inventory with an affiliated pharmacy, or moving product to another site can put the designation, and the pricing that came with it, at risk. Before signing, map your actual workflows, including prescribers, locations, and patients, and build the operation so every answer on a form stays true in practice.

You’re Not Alone

If this sounds like a lot to sort through, it is. There’s less published guidance than you might expect, answers vary by state, payor, and manufacturer, and online sources often contradict each other. That’s why it pays to go to the source. Oncology practices have been building MIDs for years, and groups like the Network of Collaborative Oncology Development & Advancement (NCODA) grew out of that work. Much of what they learned carries over to infusion. Here’s where to turn.

  • Your state board of pharmacy is the first stop for licensure questions.
  • HIBCC can walk you through the HIN application and class of trade options.
  • Wholesalers and group purchasing organizations often have teams focused on physician-owned dispensing. They can explain what their manufacturer partners expect to see on declaration forms.
  • Industry associations, including NICA, connect you with peers who have already made the move.
  • Healthcare attorneys and consultants who specialize in dispensing can review contracts and attestations before you sign.

None of these replaces your own judgment about whether MID fits your practice, but you don’t have to work it out alone.

The Bottom Line

For infusion operators, MID can be a logical extension of care already delivered in the chair, but it is not buy-and-bill with a different claim form. Moving a drug from the medical benefit to the pharmacy benefit changes who pays, how much, and under which contract. How you structure the dispensing operation then determines what your state requires of you and how manufacturers will classify you. Operators who navigate this well tend to settle these questions before buying inventory, in this order.

  1. Confirm what your state allows.
  2. Test whether your payor contracts extend to dispensing.
  3. Check each payor’s accreditation requirements.
  4. Secure the right HIN and class of trade.
  5. Design an own-use model you can attest to with confidence.

Taken in that order, and with the right help along the way, MID can be a smaller, faster build than a pharmacy.

Disclaimer: This article was written by a third-party author, not NICA. The views expressed are the authors’ own and do not constitute an endorsement by NICA. This content is for general informational purposes only and is not legal, regulatory, or financial advice. NICA makes no warranties regarding its accuracy and assumes no liability for decisions made in reliance on it. Consult qualified counsel before acting.


About the Coral Connect


Coral Connect is a tech-enabled pharmacy services platform for omnichannel pharmacy and infusion operators. We unify procurement, operations, and drug cost intelligence into a single ecosystem. 

Email: [email protected] 

Related Posts

October 22, 2026

Things to Consider When Searching for Space for Your Ambulatory Infusion Center

Things to Consider When Searching for Space for Your Ambulatory Infusion Center A practical guide to location selection, leasing, construction, and opening an ambulatory infusion center […]
June 30, 2026

The Great Migration: Why Infusion Therapy Is Moving Beyond the Hospital

Practical Revenue Cycle, Operational, and Patient Care Strategies for Today’s Independent Infusion Centers If you lead, manage, or deliver infusion therapy today, you are witnessing one […]
April 15, 2026

AI in Infusion Centers: What Actually Saves Time (and What Doesn’t)

Artificial intelligence is quickly becoming part of the conversation in infusion center operations. From prior authorization to scheduling to documentation, there’s growing interest in how AI […]
✕

Login

When you login, you will be directed to admin.infusioncenter.org. When you get there:

  • Enter the email address that was used to claim your center in the Infusion Center Locator or
  • If you are looking to add your infusion center (i.e. it does not already exist as an unclaimed location in the locator), enter the email you would like to be associated with the location.

You will receive an email with a link to click that will log you into the resources section of the locator, which includes your claimed and/or activated infusion center(s).

Please note: you will have to enter your email each time as we no longer have passwords for extra security. This login process is separate from the forum.

If you have questions about the email address associated with the location, how to add or claim a center, how to purchase a resource, etc., please email our Member Relations lead, Ashley Kana at [email protected].

✕

NICA